VON WILLEBRAND DISEASE, TYPE 3
Clinical trials for VON WILLEBRAND DISEASE, TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE, TYPE 3 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE, TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop bleeds in rare blood disorder
Disease control Recruiting nowThis study tests a medicine called emicizumab to prevent bleeding episodes in people with Type 3 von Willebrand disease, a severe inherited bleeding disorder. About 75 participants, from infants to adults, will receive either emicizumab or continue their current treatment. The go…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a simple shot replace IV treatments for severe bleeding disorder?
Disease control Recruiting nowThis study tests whether emicizumab (Hemlibra), a medicine given as a shot under the skin, can safely prevent bleeding in people with severe von Willebrand disease (VWD) or combined VWD/hemophilia A. About 40 participants of any age (including infants) will receive the drug and b…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Phase: PHASE1 • Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC